References
Komaya K, Ebata T, Shirai K, et al. Recurrence after resection with curative intent for distal cholangiocarcinoma. Br J Surg. 2017;104(4):426–33.
Tsilimigras DI, Sahara K, Wu L, et al. Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches. JAMA Surg. 2020;155(9):823–31.
Sahara K, Tsilimigras DI, Kikuchi Y, et al. Defining and predicting early recurrence after resection for gallbladder cancer. Ann Surg Oncol. 2020;28(1):417–25.
Sahara K, Tsilimigras DI, Toyoda J, Miyake K, Ethun CG, Maithel SK. Defining the risk of early recurrence following curative-intent resection for distal cholangiocarcinoma. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09811-4.
Goetze TO, Bechstein WO, Bankstahl US, et al. Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC)—a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)—the AIO/CALGP/ACO-GAIN trial. BMC Cancer. 2020;20(1):122.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ASO Author Reflections is a brief invited commentary on the article, “Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma” Ann Surg Oncol. (2021).
Rights and permissions
About this article
Cite this article
Sahara, K., Tsilimigras, D.I. & Pawlik, T.M. ASO Author Reflections: Development and Validation of Distal Cholangiocarcinoma Early Recurrence (DICER) Score: Results from the US Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol 28, 4214–4215 (2021). https://doi.org/10.1245/s10434-021-09844-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-09844-9